📰 Blockchain Payment News
Blockchain Payment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Blockchain Payment. Real-time updates on events, politics, business and more.
February 17, 2024
DUBLIN, IRELAND / ACCESSWIRE / February 17, 2024 / Kardden Token is an emerging blockchain-enabled worldwide open-source purchasing platform. In latest approach, the company has announced a series of innovative developments that position it as the ...
February 17, 2024
Kardden Unveils Innovative Token Presale, Leading the Way for Companies ...
March 26, 2022
Innovation Blockchain Payment (IBP) traded down 0.7% against the US dollar during the 1-day period ending at 14:00 PM E.T. on March 26th. In the last seven days, Innovation Blockchain Payment has traded 41.3% higher against the US dollar. Innovation Blockchain Payment has a market cap of $2.68 million and $1.05 million worth of Innovation […]
March 21, 2022
Innovation Blockchain Payment (IBP) traded 1.6% lower against the dollar during the twenty-four hour period ending at 23:00 PM E.T. on March 20th. In the last week, Innovation Blockchain Payment has traded 1% higher against the dollar. One Innovation Blockchain Payment coin can currently be purchased for about $0.0102 or 0.00000025 BTC on cryptocurrency exchanges. […]
July 29, 2021
(Photo : Who Will Win the Blockchain Payment Race? ) When Satoshi Nakamoto created Bitcoin, the original intention, as stated in the white paper, was for it to be "a peer-to-peer electronic cash system." For the avoidance of any doubt, Satoshi referred to "the possibility for small casual transactions" and the concepts of disputes between merchants and buyers in the introductory paragraph. Therefore, Satoshis objective that Bitcoin was a medium of exchange was in evidence from the very beginn...
May 18, 2021
A glance at some of the days highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Mydecine Innovations Group Inc (NEO:MYCO) (OTCMKTS:MYCOF) (FRA:0NFA) announced that it ended the first quarter of 2021 with cash and equivalents of C$11.3 million, which the company said will help it advance its intellectual property portfolio, build out its clinical trial calendar, expand its European operations and develop its technology divi...